Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN

Author:

Gabre Jonatan L123ORCID,Merseburger Peter123ORCID,Claeys Arne12ORCID,Siaw Joachim123ORCID,Bekaert Sarah-Lee24ORCID,Speleman Frank24ORCID,Hallberg Bengt3ORCID,Palmer Ruth H3ORCID,Van den Eynden Jimmy12ORCID

Affiliation:

1. Department of Human Structure and Repair, Anatomy and Embryology Unit, Ghent University , Ghent , Belgium

2. Cancer Research Institute Ghent , Ghent , Belgium

3. Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden

4. Department of Biomolecular Medicine, Ghent University , Ghent , Belgium

Abstract

Abstract Neuroblastoma (NB) is the most common cancer in infancy with an urgent need for more efficient targeted therapies. The development of novel (combinatorial) treatment strategies relies on extensive explorations of signaling perturbations in neuroblastoma cell lines, using RNA-Seq or other high throughput technologies (e.g. phosphoproteomics). This typically requires dedicated bioinformatics support, which is not always available. Additionally, while data from published studies are highly valuable and raw data (e.g. fastq files) are nowadays released in public repositories, data processing is time-consuming and again difficult without bioinformatics support. To facilitate NB research, more user-friendly and immediately accessible platforms are needed to explore newly generated as well as existing high throughput data. To make this possible, we developed an interactive data centralization and visualization web application, called CLEAN (the Cell Line Explorer web Application of Neuroblastoma data; https://ccgg.ugent.be/shiny/clean/). By focusing on the regulation of the DNA damage response, a therapeutic target of major interest in neuroblastoma, we demonstrate how CLEAN can be used to gain novel mechanistic insights and identify putative drug targets in neuroblastoma.

Funder

Ghent University Special Research Fund

Research Foundation Flanders

Belgian Foundation Against Cancer

Flemish Cancer Society

Swedish Cancer Society

Swedish Childhood Cancer Foundation

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3